These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18430754)

  • 1. Pathological and molecular features of adrenocortical carcinoma: an update.
    Volante M; Buttigliero C; Greco E; Berruti A; Papotti M
    J Clin Pathol; 2008 Jul; 61(7):787-93. PubMed ID: 18430754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncocytic adrenocortical carcinoma.
    Ohtake H; Kawamura H; Matsuzaki M; Yokoyama E; Kitajima M; Onizuka S; Yamakawa M
    Ann Diagn Pathol; 2010 Jun; 14(3):204-8. PubMed ID: 20471567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical carcinoma: review and update.
    Erickson LA; Rivera M; Zhang J
    Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
    Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
    Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in surgical pathology of adrenocortical tumours.
    Erickson LA
    Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.
    Volante M; Bollito E; Sperone P; Tavaglione V; Daffara F; Porpiglia F; Terzolo M; Berruti A; Papotti M
    Histopathology; 2009 Nov; 55(5):535-43. PubMed ID: 19912359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis of adrenocortical cancer.
    Lehmann T; Wrzesinski T
    Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical Oncocytic Carcinoma: A Case Report and Review of the Histopathologic Diagnostic Criteria.
    Arik D; Canaz F; Dündar E
    Turk Patoloji Derg; 2016; 32(3):211-5. PubMed ID: 27562395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
    Blanes A; Diaz-Cano SJ
    Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.
    Duregon E; Volante M; Cappia S; Cuccurullo A; Bisceglia M; Wong DD; Spagnolo DV; Szpak-Ulczok S; Bollito E; Daffara F; Berruti A; Terzolo M; Papotti M
    Am J Surg Pathol; 2011 Dec; 35(12):1882-93. PubMed ID: 21989346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
    Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
    Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
    J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of adrenocortical tumors morphology as regards their structure and potential malignancy].
    Kajor M; Ziaja J; Król R; Ciupińska-Kajor M; Dobrosz Z; Heitzman M; Cierpka L
    Endokrynol Pol; 2006; 57(2):136-42. PubMed ID: 16773589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma].
    Selivanova LS; Roslyakova AA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
    Arkh Patol; 2019; 81(5):92-96. PubMed ID: 31626211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.
    Duregon E; Volante M; Giorcelli J; Terzolo M; Lalli E; Papotti M
    Hum Pathol; 2013 May; 44(5):822-8. PubMed ID: 23158211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
    Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
    Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
    Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
    Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.